BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.494
-0.004 (-0.82%)
Jan 23, 2025, 12:14 PM EST - Market open
BioAtla Market Cap
BioAtla has a market cap or net worth of $28.69 million as of January 23, 2025. Its market cap has decreased by -74.85% in one year.
Market Cap
28.69M
Enterprise Value
-26.34M
1-Year Change
-74.85%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $28.69M, a decrease of -95.03%. That is a compound annual growth rate of -51.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 28.93M | -15.68% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.91B |
| UnitedHealth Group | 478.29B |
| Novo Nordisk | 360.47B |
| Johnson & Johnson | 349.76B |
| AbbVie | 299.00B |
| Merck & Co. | 242.01B |
| Thermo Fisher Scientific | 219.78B |
| Intuitive Surgical | 217.43B |